Although there is no certain relationship between the specific PTPN11 mutation and the incidence of cancer, almost 15% of brain tumors in PTPN11 mutation-associated NS were associated with the heterozygous form of the p.Asn308Asp mutation. Here, PTPN11 is linked to cancer.